Bad news for stop–start therapy?

Andrew J. McMichael () and Sarah L. Rowland-Jones ()
Additional contact information
Andrew J. McMichael: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Sarah L. Rowland-Jones: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital

Nature, 2002, vol. 420, issue 6914, 371-373

Abstract: An HIV-infected patient who was being treated with anti-retroviral drugs in a 'stop–start' protocol has become infected with a second HIV strain, raising questions about both the treatment strategy and vaccine development.

Date: 2002
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/420371a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:420:y:2002:i:6914:d:10.1038_420371a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/420371a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().